-

Hims & Hers Expands Women’s Health Offerings With Support For Urinary Tract Health

D-Mannose powder packets are one of the latest offerings, furthering company’s mission to provide more access, ease and personalization to solutions for women’s health needs

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently expanded its women’s health offerings with the recent launch of a D-Mannose dietary supplement powder to support urinary tract health on ForHers.com. This most recent holistic offering reiterates the company’s mission to provide consumers with products - both over the counter and prescription, as recommended by medical practitioners - access to the health solutions they need without the hassles accompanied by traditional methods.

“Roughly 3 or 4 in 10 women who experience an initial urinary tract infection (UTI) will face another one within six months. There’s a clear need for ways to be proactive about urinary tract health,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “It is important to have holistic, over the counter options to promote the various elements of women’s health, which is why we are now offering these tasty single-serve packets formulated with vitamins and electrolytes that have been shown to help maintain urinary tract balance.”

The powder, which comes in packages of 10 cranberry-raspberry flavored single-serve packets, supports a healthy urinary system with a combination of D-Mannose, a sugar found in cranberry juice, three electrolytes (calcium, magnesium and potassium) and antioxidants (vitamins C and B6). Consumers can purchase as part of a discounted subscription or as a one-time purchase.

In addition to the UT powder, the company offers a wide variety of sexual health products and services including access to treatment for erectile dysfunction, premature ejaculation, genital herpes and cold sores, condoms and lubricants, vibrators and birth control pills, as well as a variety of wellness supplements including unflavored collagen protein powder, and biotin gummies. For more information about the D-Mannose Powder, please visit www.forhers.com/sexual-health/ut-powder.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers recently expanded its women’s health offerings with the launch of a D-Mannose dietary supplement powder to support urinary tract health.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new injectable and oral testosterone replacement therapies (TRT) for eligible men. It’s the largest expansion of the company’s men’s health program since first introducing the category last September, giving eligible men more options to treat low testosterone in partnership with licensed providers through Hims. An estimated 20 million men1,2 i...

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 9, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and (585) 542-9983 for international participant...

Hers Launches in Australia, Built to Care for the Whole Woman

SYDNEY--(BUSINESS WIRE)--Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, bringing its personalised care platform to women nationwide for the first time. The launch introduces first-of-their-kind treatment programs across Hair, Menopause and Perimenopause, and Weight Loss care - backed by women's-only research and 24/7 Care Team access. The launch marks the rebrand of Juniper, Eucalyptus' women's health platform, which h...
Back to Newsroom